Portfolio map · Private equity · United States

OrbiMed portfolio map

221 startups OrbiMed has backed in rounds we track, since 2002, grouped by their main sector. Together they have raised $34B; OrbiMed led at least one round in 7 of them. The biggest sector is Biotech, with 176 companies.

221startups backed
4sectors
$34Braised between them
Biotechbiggest sector

OrbiMed's investor profile

Biotech

176

+152 more

Pharma

26

+2 more

Healthtech

13

AI

6

Segment by segment

Biotech

176 startups · $28B raised

  1. Apogee TherapeuticsApogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.United States$1.3B
  2. Guardant HealthGuardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.United States$800M
  3. ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$739M
  4. Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
  5. Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.United States$675M
  6. Verdiva BioVerdiva Bio is a clinical-stage biopharmaceutical company based in Guildford, United Kingdom, founded in 2024.United Kingdom$601M
  7. Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.United States$600M
  8. Avalo TherapeuticsAvalo Therapeutics is a clinical-stage biopharmaceutical company.United States$501M

Pharma

26 startups · $3.7B raised

  1. Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.United States$788M
  2. Corvus PharmaceuticalsCorvus Pharmaceuticals is a clinical-stage biopharmaceutical company.United States$310M
  3. ACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.United States$300M
  4. Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.United States$280M
  5. Harmony BiosciencesHarmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.United States$248M
  6. ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
  7. Adicet BioAdicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for caUnited States$175M
  8. Aduro BioTechAduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.United States$143M

Healthtech

13 startups · $1.4B raised

  1. TricidaTricida operates in the healthcare industry focusing on pharmaceutical business.United States$327M
  2. BYBeijing Yuan XinBeijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.-$232M
  3. Edge Medical RoboticsEdge Medical Robotics is a surgical robot platform company focused on design, R&D, and commercialization of advance medical devices.-$200M
  4. AugmedixAugmedix, a Commure company, empowers clinicians to connect with patients by liberating them from administrative burden through thUnited States$90M
  5. SpectronRxSpectronRx is a specialized radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) founded in 2004, with hUnited States$85M
  6. PMProVerum MedicalIreland$80M
  7. Unilife CorporationUnilife is a U.S-based medical device and technology company that designs, develops, manufactures and supplies innovative.United States$75M
  8. Noctrix HealthNoctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.United States$74M

AI

6 startups · $727M raised

  1. DELFI DiagnosticsDELFI Diagnostics is a biotechnology company founded in 2019 that focuses on early cancer detection through a blood-based liquid bUnited States$259M
  2. CHARM TherapeuticsCHARM Therapeutics is a London-based biotechnology company founded in 2021.United Kingdom$149M
  3. ConstellationInvesting in founders building the future of healthcareFrance$125M
  4. MendraMendra is an AI-native biopharmaceutical company based in San Francisco, founded in 2025.United States$82M
  5. EvozyneEvozyne is a biotechnology company based in Chicago, Illinois, focused on designing and developing innovative protein therapeuticsUnited States$81M
  6. Altis LabsAltis Labs, Inc.Canada$31M

How this map is made. Every startup here has raised money in a round we track that names OrbiMed as an investor, the first in 2002. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Private equity · United StatesGaingels493 startups · 12 sectors · $40BPrivate equity · United StatesGoldman Sachs294 startups · 12 sectors · $163BPrivate equity · United StatesPioneer Fund289 startups · 12 sectors · $5.9BPrivate equity · United StatesRA Capital Management264 startups · 5 sectors · $48BPrivate equity · United StatesCormorant Asset Management123 startups · 3 sectors · $25BPrivate equity · United StatesMorgan Stanley Investment Management112 startups · 12 sectors · $171B

Raising from investors like OrbiMed?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps